Travere Therapeutics (TVTX) Debt Ratio (2013 - 2025)

Travere Therapeutics has reported Debt Ratio for 13 years, with the latest figure at 0.12 in Q2 2025.

• For the quarter ending Q2 2025, Debt Ratio changed N/A year-over-year to 0.12; the trailing twelve-month figure through Jun 2025 stood at 0.12 (changed N/A YoY), and the FY2024 full-year result was 0.12, changed N/A from the prior year.
• Debt Ratio for Q2 2025 stood at 0.12, down from 0.13 in the prior quarter.
• The five-year high for Debt Ratio was 0.14 in Q3 2024, with the low at 0.01 in Q1 2023.
• Historically, Debt Ratio has averaged 0.05 across 5 years, with a median of 0.01 in 2022.
• Annual changes were most pronounced in 2021 — Debt Ratio plunged 66.74% — and 2022, when it advanced 9.23%.
• Travere Therapeutics' Debt Ratio stood at 0.01 in 2021, then gained by 9.23% to 0.01 in 2022, then declined by 9.97% to 0.01 in 2023, then soared by 1133.73% to 0.12 in 2024, then climbed by 7.24% to 0.12 in 2025.
• The last three Debt Ratio figures came in at 0.12 (Q2 2025), 0.13 (Q1 2025), and 0.12 (Q4 2024), per Business Quant data.